Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
about
[Choosing wisely recommendations in cardiology].Examining Bias in Studies of Statin Treatment and Survival in Patients With Cancer.Commercial Online Social Network Data and Statin Side-Effect Surveillance: A Pilot Observational Study of Aggregate Mentions on Facebook.Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects.Novel treatment options for portal hypertension.Targeting LDL Cholesterol: Beyond Absolute Goals Toward Personalized Risk.Do Statins Have Antidepressant Effects?Cardiovascular disease prevention strategies for type 2 diabetes mellitus.Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies.Strategies to Prioritize Clinical Options in Primary Care.Longitudinal trends and predictors of statin use among patients with diabetes.Editorial: Statins and Liver Disease: Is it Time to Recommend Statins to Prevent Liver Disease Progression?Effect of Therapeutic Hypothermia Initiated After 6 Hours of Age on Death or Disability Among Newborns With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial.Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer.Serious Adverse Events Among SPRINT Trial Participants Taking Statins at Baseline.Ten-Year Mortality in the WISE Study (Women's Ischemia Syndrome Evaluation).The Use of Primary Prevention Statin Therapy in Those Predisposed to Atherosclerosis.Trajectory of Total Cholesterol in The Last Years of Life Over Age 80 Years. Cohort Study of 99,758 Participants.Pharmacological Prevention of Cardiovascular Outcomes in Diabetes Mellitus: Established and Emerging Agents.Statins induce apoptosis through inhibition of Ras signaling pathways and enhancement of Bim and p27 expression in human hematopoietic tumor cells.Statin therapy exacerbates alcohol-induced constriction of cerebral arteries via modulation of ethanol-induced BK channel inhibition in vascular smooth muscle.The significance of cholesterol and its metabolite, 27-hydroxycholesterol in breast cancer.All-Round Manipulation of the Actin Cytoskeleton by HIV.Effect of low-density lipoprotein cholesterol on the geometry of coronary bifurcation lesions and clinical outcomes of coronary interventions in the J-REVERSE registry.Statin Therapy and Risk of Diabetes Mellitus in Aging Patients With Heterozygous Familial Hypercholesterolemia or Familial Combined Hyperlipidemia: A 10-Year Follow-Up.Cost-effectiveness analysis of asymptomatic peripheral artery disease screening with the ABI test.Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology/European Atherosclerosis Society guidelines: a contemporary population-based study.Dyslipidaemia in the elderly: to treat or not to treat?Editorial: Prevention of Rheumatoid Arthritis: Now Is the Time, but How to Proceed?Association of change in total cholesterol level with mortality: A population-based study.Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma.Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts.Reporting bias in the literature on the associations of health-related behaviors and statins with cardiovascular disease and all-cause mortality.The influence of the intestinal microflora to the efficacy of Rosuvastatin.Beneficial effect of statins in patients receiving chronic hemodialysis following percutaneous coronary intervention: A nationwide retrospective cohort study.
P2860
Q30313178-60ACADE9-9791-47B0-9ACB-370B32FB37E6Q38617408-15A2ADD4-210C-4E49-A9E6-65636EBAEFB8Q38651225-27166A75-EC03-4491-A491-88D0F834663BQ38656007-6780D053-9323-4EFD-B467-BF0FAB46E688Q38680437-3F5147FA-FC56-41CD-A3E9-2D438237BBC8Q38825508-561E8E0F-1DC6-4C79-AC18-C03CC0776BC9Q39183235-3B23051E-D716-4ABB-8025-7B05133386DEQ39420208-A023F57E-66A0-40DF-A234-71915BA63DEAQ40107412-F7720BAB-0A49-4FA8-8AF6-EC844CC6DA62Q42333441-2FF53F5C-751D-40EB-88C1-56D2682CA855Q45072054-E8021A2B-322B-4AE2-BC62-E65C73BCFA11Q46131886-A7BF4AB2-80D5-4CC3-BAAC-B016EEEAF3B1Q46638489-4E1BF9D4-9075-4BF4-8956-8685DD85B856Q47298592-D9FD0627-8F68-4D7E-AA48-020C8F52C40EQ47336691-5E580196-F6A9-4537-BF84-468E841B4919Q47348124-75C72F8E-9A69-4802-B3A9-2F121B1F83CFQ47610317-D1FB1D62-5515-48BF-98D5-D5E7C98440ACQ47651470-5144E4BA-4AD0-4BDE-B26C-3010392F1A2EQ47663088-72D8DA41-AC8F-4476-B166-3336D02CE6EBQ47679039-9F2C3BBE-6743-4339-855E-275D3948D420Q47865448-47E0C9CF-E1DA-4DAB-B576-B7409A951413Q47944717-0BB2CA1D-1D23-416B-B998-A948E06CE906Q48104489-BA4C44BB-3632-4521-B976-56474B4F3040Q48157896-0BA31840-5E30-4B93-8833-23218E99E8E0Q48168322-4709C63B-DCED-40FC-971C-6B7F625FE023Q48219740-6D0FFF89-3F96-4D0F-9A69-6BEC46F20263Q49574252-D1FD1AEB-99ED-40C0-BE46-4A3221700A31Q50180407-7FE05C5C-74AA-4C8A-8EC1-3B01B590777BQ50882987-A5462DC0-4426-4EB9-8AC9-BA6D6B7F8472Q52577919-F2E36CCE-99F6-422B-B8A8-4DD31E9E6B96Q55195973-2BD13538-B0CA-44EE-A56D-0713B458751AQ55278677-9907477B-564F-4D78-BC38-CC61452A2187Q55425023-4885EC29-AAB3-402D-BF07-3691F46D7C4AQ55497625-24F498AB-D8A7-4CAE-BB6D-39871D9835B9Q55512228-3B741573-A865-49BC-A7F5-1C9D2C4EE63E
P2860
Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Statins for Prevention of Card ...... reventive Services Task Force.
@ast
Statins for Prevention of Card ...... reventive Services Task Force.
@en
type
label
Statins for Prevention of Card ...... reventive Services Task Force.
@ast
Statins for Prevention of Card ...... reventive Services Task Force.
@en
prefLabel
Statins for Prevention of Card ...... reventive Services Task Force.
@ast
Statins for Prevention of Card ...... reventive Services Task Force.
@en
P2093
P31
P356
P1476
Statins for Prevention of Card ...... reventive Services Task Force.
@en
P2093
Ian Blazina
Monica Daeges
Roger Chou
Tracy Dana
P304
P356
10.1001/JAMA.2015.15629
P407
P577
2016-11-01T00:00:00Z